An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial
Authors' conclusion
Among adults with T2D, use of an integrated digital health care platform with AI-driven dietary management resulted in better glycemia and more weight loss.
Study context
- Population
- Overweight or obese adults with T2D
- Participants
- 294 participants
- Comparison
- Integrated digital health care platform with artificial intelligence (AI)-based dietary management (alone or with medical staff feedback and intermittent CGM) vs routine diabetes care
- An = 99reference
- Bn = 97
- Cn = 98
- Primary endpoint
- Difference of change in HbA1c from baseline between groups A and B
- Follow-up
- 24 weeks
Methodological detailsopen-label, multicenter, 1:1:1 randomization, 48-week
- Open-label
- Multicenter
- 1:1:1 randomization
- 48-week
Primary result
As reported in the abstract
Change in HbA1c · baseline to 24 weeks
A
−0.06
± 0.61 · %
B
−0.32
± 0.58 · %
C
−0.49
± 0.57 · %
Secondary outcomes
| Outcome | A | B | C |
|---|---|---|---|
| Change in HbA1c · baseline to 48 weeks | 0.07 ± 0.78 % | −0.28 ± 0.56 % | −0.44 ± 0.62 % |
Change in HbA1c · baseline to 48 weeks
- Decreases in HbA1c in B and C significantly larger than in A
Weight loss · baseline to 24 and 48 weeks
- B and C greater weight loss than A from baseline to 24 weeks
- C more weight loss than A from baseline to week 48
Original publication
An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes Care. Published 23 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →